Expert report review
Amended, reissued or published claims: which version must the opposing expert compare with the product?
An infringement comparison is only as good as the claim it uses. Claims change after filing: they are published in an application, allowed in a different form, reissued, amended or cancelled in an inter partes review. Each change can move the date from which the patent owner may recover and can give the accused infringer intervening rights. A review of the opposing report starts by checking which version of each claim the expert compared.

Which version of the claims does an infringement comparison use?
The claims in force for the period of the accused acts: the issued claims, or the claims as reissued, amended or confirmed after a post-grant proceeding. Earlier text matters only under specific statutory rules.
The patent grants "the right to exclude others from making, using, offering for sale, or selling the invention throughout the United States," in the words of 35 U.S.C. 154(a)(1), and the invention is defined by the claims of the patent. The expert who compares a product with a claim therefore has to say which claim text is used and for which period.
The text can change several times. An application is published with one set of claims, the patent issues with another, a reissue can enlarge or narrow the claims, and an inter partes review or reexamination can cancel some claims, confirm others and add amended or new ones. Each event has its own statutory consequence for past and future acts.
A review of the opposing report therefore starts with a table of versions: the claim text the expert quotes, the document it comes from (publication, issued patent, reissue, certificate), the date of that document, and the period of the accused acts the expert compares with it.
Can the expert compare the product with the claims of a published application?
Only for provisional rights under 35 U.S.C. 154(d): a reasonable royalty for acts after publication, if the infringer had actual notice and the issued claims are substantially identical to the published ones.
Section 154(d)(1) gives the patent owner a right to obtain "a reasonable royalty from any person who" makes, uses, offers for sale, sells or imports the invention as claimed in the published application during the period between publication and issue, if that person "had actual notice of the published patent application."
Section 154(d)(2) limits the right: it "shall not be available under this subsection unless the invention as claimed in the patent is substantially identical" to the invention as claimed in the published application.
An expert who compares a product with the published claims must therefore do two comparisons. The first is the product against the published claim, for the pre-issue period. The second is the published claim against the issued claim, to show that the two are substantially identical. A report that charts only the published claim, or only the issued one, leaves half of the provisional rights question open.
What happens to the comparison after a reissue?
For later causes of action the reissued patent has the same effect as if originally granted in its amended form. Claims that are substantially identical continue the original patent, and intervening rights protect some earlier acts.
Under 35 U.S.C. 252, a reissued patent has the same effect in law for causes of action arising after the reissue "as if the same had been originally granted in such amended form." Where claims of the original and reissued patents are "substantially identical," the surrender of the original patent does not affect pending actions, and the reissued patent continues the original from its date.
The second paragraph of section 252 protects intervening rights. A reissue does not take away the rights of a person who, before the reissue, made, purchased, offered to sell, used or imported the thing patented, unless the person's acts infringe "a valid claim of the reissued patent which was in the original patent." The court may also allow continued manufacture, use or sale, including where substantial preparation was made before the reissue, on terms it considers equitable.
For the reviewer, the question is which reissued claims were in the original patent and which are new or changed. An infringement opinion that applies a new reissue claim to acts before the reissue needs the intervening-rights analysis; one that applies an original claim carried into the reissue unchanged needs the substantially identical comparison.
What if claims were amended or cancelled in an inter partes review?
The certificate after an IPR cancels unpatentable claims, confirms patentable ones and incorporates amended or new claims. Amended or new claims carry intervening rights under 35 U.S.C. 318(c) for acts before the certificate.
Under 35 U.S.C. 318(b), once the time for appeal has expired or any appeal has terminated, the Director "shall issue and publish a certificate canceling any claim of the patent finally determined to be unpatentable, confirming any claim of the patent determined to be patentable, and incorporating in the patent by operation of the certificate any new or amended claim determined to be patentable."
Section 318(c) then reads: "Any proposed amended or new claim determined to be patentable and incorporated into a patent following an inter partes review under this chapter shall have the same effect as that specified in section 252 for reissued patents on the right of any person who made, purchased, or used within the United States, or imported into the United States, anything patented by such proposed amended or new claim, or who made substantial preparation therefor, before the issuance of a certificate under subsection (b)."
An opposing report written before the IPR ended can therefore rest on claims that no longer exist or have changed. The review checks the final written decision and the certificate, lists each claim the report addresses with its status (cancelled, confirmed, amended, new), and flags every opinion that depends on a cancelled claim or on the pre-amendment text of an amended one.
Do intervening rights arise when the claim text did not change?
No, under Marine Polymer v. HemCon (en banc, 2012). The Federal Circuit held intervening rights unavailable under section 307(b) where the asserted claims were neither amended nor new, although their scope had been argued during reexamination.
Marine Polymer Technologies, Inc. v. HemCon, Inc., No. 2010-1548, was decided by the en banc Federal Circuit on March 15, 2012. Judge Lourie wrote the opinion for the court in part; Judge Dyk dissented in part. The district court had found that HemCon infringed Marine Polymer's '245 patent after construing the term "biocompatible." During a reexamination requested by HemCon, Marine Polymer cancelled six dependent claims and urged the district court's construction of "biocompatible," and the examiner confirmed the remaining claims without changing their text.
HemCon argued that intervening rights applied because the scope of the claims had changed. A majority of the en banc court rejected that argument: "Intervening rights are therefore unavailable under § 307(b) as a matter of law." The court reasoned that section 307(b) reaches only amended or new claims, and wrote of the claims in suit: "The asserted claims of the '245 patent are neither." The court concluded: "Accordingly, the final judgment of the district court is affirmed."
For the review, Marine Polymer sets a text test. The reviewer compares the claim language before and after the proceeding word by word. If the words are the same, the intervening-rights argument fails under that decision, whatever was said about the claims during reexamination; if the words changed, the analysis of 252 and 318(c) or 307(b) applies.
Why does the claim version change the damages period?
Because each statute ties recovery to dates: publication for provisional rights, issue for ordinary infringement, the reissue or the IPR certificate for amended claims. An expert who uses the wrong version can count the wrong years.
The provisional-rights period under 154(d) runs from publication of the application until the patent issues. Ordinary infringement under section 271 runs during the term of the patent. For amended or new claims after an IPR, 318(c) protects acts before the certificate; for reissued claims that were not in the original patent, section 252 protects acts before the reissue.
A damages expert relies on the technical expert for the claims and dates. If the technical report applies an amended claim to sales before the certificate, the royalty base is built on acts that the statute may protect, and both reports have to be corrected together.
The review therefore lists, for each claim, the period during which it can support recovery, and checks that the technical and damages reports use the same version and the same period.
What does a review of the opposing report check about claim versions?
The source and date of each quoted claim, its status after any reissue, reexamination or IPR, whether it is substantially identical to earlier text, the period it is applied to, and whether any opinion rests on a cancelled claim.
The review builds the version table described above and attaches the documents: the published application, the issued patent, any reissue, the final written decision and the certificate. Each row of the expert's claim chart is checked against the right document.
Where the report relies on a claim whose text changed, the review states what changed, whether the change narrows or broadens the element in question, and how the change affects the opinion. Where the report relies on text that did not change, the review notes it, because under Marine Polymer that settles the intervening-rights question for that claim.
Rule 702 of the Federal Rules of Evidence requires that the testimony rest on sufficient facts or data and that the method be reliably applied to the facts of the case. An infringement opinion on a claim that has been cancelled, or on a version that does not govern the period of the accused acts, is not applied to the facts of the case.
What does IAE do when the claims changed during the case?
An IAE reviewer checks the opposing technical expert's report against the claim versions that govern each period and prepares the points for the rebuttal and the deposition, in up to 5 business days.
The patent report review page describes the review as a check of whether every opinion is tied to the claim language and the evidence: each element mapped, the court's claim construction applied, sufficient facts or data under Rule 702(b). Before work starts IAE confirms the patent, the asserted claims and the questions for the reviewer.
The client sends the opposing report with its exhibits, the published application, the issued patent and any reissue, reexamination or IPR certificate, and the claim construction order. The secretariat confirms receipt the same day; within one business day IAE confirms the format, the cost, the deadline and the reviewer from its registry, and the client approves the candidate and the CV. Cases with tight deadlines have a 48-hour rush.
Every reviewer is a member of the public IAE registry, verifiable by Member ID or QR code, and confirms in the document that he or she has no interest in the outcome of the case. A review is material that the court weighs with the other evidence, and neither IAE nor the reviewer guarantees the outcome. IAE is not a law firm and does not advise on case strategy.
Sources
- 35 U.S. Code 154, Contents and term of patent; provisional rights (LII, Cornell Law School)
- 35 U.S. Code 252, Effect of reissue (LII, Cornell Law School)
- 35 U.S.C. 318, Decision of the Board (U.S. Code 2024, govinfo)
- Marine Polymer Technologies, Inc. v. HemCon, Inc., 672 F.3d 1350 (Fed. Cir. 2012) (en banc)
- Federal Rules of Evidence, Rule 702 (LII, Cornell Law School)
Read also
All articles
Enablement and written description in the opposing invalidity report: what does a reviewer check after Amgen v. Sanofi?
An invalidity report under 35 U.S.C. 112 says that the patent's specification does not describe the invention or does not teach a skilled person
Is the opposing patent expert a person of ordinary skill in the art, and what follows if not?
Claim construction, obviousness and infringement are all judged through the eyes of a person having ordinary skill in the art. In Kyocera Senco
Anticipation in the opposing invalidity report: does one reference really disclose every element as claimed?
A claim is anticipated only if a single prior art reference discloses every limitation, expressly or inherently, arranged as the claim arranges itExpert report review
Ready to discuss your case?
Send the materials: the secretariat will confirm the format, cost, deadline and the specialist within one business day.

